NCT06200636View on ClinicalTrials.gov

Edge AI-deployed DIGItal Twins for PREDICTing Disease Progression and Need for Early Intervention in Infectious and Cardiovascular Diseases Beyond COVID-19 - Investigation of Biomarkers in Dermal Interstitial Fluid

NANot yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

November 1, 2024

Study Completion Date

November 1, 2024

Conditions
Heart Failure
Interventions
DEVICE

Use of the PELSA System for dISF extraction

Dermal interstitial fluid will be extracted using the investigational device, for further analysis.

Trial Locations (1)

13353

Deutsches Herzzentrum der Charité, Berlin

All Listed Sponsors
lead

Charite University, Berlin, Germany

OTHER

NCT06200636 - Edge AI-deployed DIGItal Twins for PREDICTing Disease Progression and Need for Early Intervention in Infectious and Cardiovascular Diseases Beyond COVID-19 - Investigation of Biomarkers in Dermal Interstitial Fluid | Biotech Hunter | Biotech Hunter